Acceptance of biological samples and associated data between countries will be facilitated if biobanks can propose validation protocols for their samples and ensure the accuracy of the results obtained from the samples. This has revealed the need to optimize management of these biospecimens such that research biorepositories can guarantee that samples distributed to industry or academic researchers are comparable and without institute-dependent intrinsic bias. An increasing number of biospecimens are being collected in the context of multicenter and international clinical studies and diagnostics.
0 kommentar(er)
